Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Illerhaus

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Neuro-Oncology|September 15, 2023
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomasEliza M Lauer, Ella Riegler, Jurik A Mutter, et al.
Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.
The Lancet. Haematology|August 2, 2016
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trialGerald Illerhaus, Benjamin Kasenda, Gabriele Ihorst, et al.
Frontiers in Immunology|December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patientsJonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Neuro-Oncology|February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
BMC Cancer|August 18, 2023
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trialLisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, et al.
Blood|September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphomaLorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Haematologica|October 27, 2022
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphomaJahanzaib Khwaja, Amy A Kirkwood, Lisa K Isbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2022
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain LymphomasJurik A Mutter, Stefan K Alig, Mohammad S Esfahani, et al.
JAMA Oncology|April 28, 2017
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 TrialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Neuro-Oncology|September 15, 2023
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomasEliza M Lauer, Ella Riegler, Jurik A Mutter, et al.
Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.
The Lancet. Haematology|August 2, 2016
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trialGerald Illerhaus, Benjamin Kasenda, Gabriele Ihorst, et al.
Frontiers in Immunology|December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patientsJonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Neuro-Oncology|February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
BMC Cancer|August 18, 2023
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trialLisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, et al.
Blood|September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphomaLorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Haematologica|October 27, 2022
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphomaJahanzaib Khwaja, Amy A Kirkwood, Lisa K Isbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2022
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain LymphomasJurik A Mutter, Stefan K Alig, Mohammad S Esfahani, et al.
JAMA Oncology|April 28, 2017
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 TrialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Pageof 8